Cromolyn Sodium (cromolyn sodium)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Cromolyn sodium has been described as a mast-cell stabilizer.

USES: This medication is used to prevent symptoms (wheezing and shortness of breath) caused by asthma. It is also used to prevent wheezing and shortness of breath caused by exercise, cold/dry/polluted air, or allergens such as pollen. Controlling breathing problems may decrease time lost from work or school.

If you use this medication you may not need to use other asthma drugs (such as corticosteroids) as often. Cromolyn belongs to a class of medications called mast cell stabilizers. It works by preventing release of certain natural chemicals (such as histamines) that may cause swelling of the airways and breathing problems.

This medication must be used regularly to prevent asthma symptoms. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler as prescribed.

Generic name: cromolyn sodium
Pronunciation: (KROE-mo-lin)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Cromolyn Sodium

Intelligence content is not available yet.

Indications

The following indications are listed for Cromolyn Sodium:

  • Maintenance Therapy For Asthma

Also known as: Therapy To Achieve Long-Term Asthma Control.

Dosing

The oral aerosol inhaler delivers 800 mcg of cromolyn sodium per metered spray from the mouthpiece. The commercially available aerosol containing 8.1 or 14.2 g of drug delivers at least 112 or 200 metered sprays, respectively; the canister should be discarded after the labeled number of actuations have been used since the correct drug dose per inhalation cannot be assured if used for additional doses.

Although cromolyn sodium is only minimally absorbed (up to 1%) following oral administration, the absorbed portion undergoes renal and biliary elimination. Severe anaphylactic reactions may occur rarely in patients receiving cromolyn sodium, and the manufacturer states that oral dosage of the drug should be reduced in patients with impaired renal or hepatic function. Dosage reduction of cromolyn sodium given via oral inhalation also should be considered in patients with renal or hepatic impairment.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data